Direct AAV-mediated gene delivery to the temporomandibular joint

被引:11
|
作者
Dai, Juan [1 ]
Bakr, A. [1 ]
Rabie, M. [1 ]
机构
[1] Univ Hong Kong, Fac Dent, Biomed & Tissue Engn Grp, Hong Kong, Hong Kong, Peoples R China
来源
关键词
gene therapy; adeno-associated virus; enhanced green fluorescence protein; PCR; mandibular condyle;
D O I
10.2741/2224
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Successful intra-temporomandibular joint gene transfer is a prerequisite for gene therapy to induce mandibular condylar growth. This study was carried out to investigate the expression of recombinant adeno-associated virus ( rAAV) based vector-mediated enhanced green fluorescence protein ( eGFP) in the mandibular condyle. The transduction efficiencies for primary chondrocytes using different hybrids of rAAV vectors were identified by fluorescence microscopy and FACS. Sprague-Dawley rats were injected with either rAAV(2/2)-eGFP construct or saline into both mandibular condyles. The spatial and temporal transgene expression was detected by in situ hybridization, RT-PCR and real-time PCR. Our result showed that rAAVs were capable of infecting rat chondrocytes. rAAV(2/2) was the best serotype to infect chondrocytes in vitro. By in situ hybridization, eGFP expression was clearly detected in the deeper layer of mandibular condyle as early as 7 days after injection. By real-time PCR, the transgene expression reached a peak at 21 days. This study was the first report to explore that rAAV-mediated genes could be transferred to mandibular condyle in vivo. Our results strongly suggest that rAAV(2/2) mediated gene delivery is a promising approach to deliver candidate genes for future regulating mandibular condylar growth.
引用
收藏
页码:2212 / 2220
页数:9
相关论文
共 50 条
  • [41] Cytostatic drugs enhance AAV-mediated gene targeting
    Rahman, Shamim
    Gellhaus, Katharina
    Montazami, Kaweh
    Heilbronn, Regine
    Cathomen, Toni
    HUMAN GENE THERAPY, 2009, 20 (11) : 1501 - 1502
  • [42] Homologous recombination is required for AAV-mediated gene targeting
    Vasileva, Ana
    Linden, R. Michael
    Jessberger, Rolf
    NUCLEIC ACIDS RESEARCH, 2006, 34 (11) : 3345 - 3360
  • [43] AAV-Mediated Gene Therapy for the Treatment of Retinal Diseases
    Rolling, Fabienne
    CURRENT GENE THERAPY, 2010, 10 (05) : 318 - U4
  • [44] AAV-Mediated Gene Transfer for the Treatment of the Alport Syndrome
    Schievenbusch, Stephanie
    Strack, Ingo
    Scheffler, Melanie
    Hallek, Michael
    Dienes, Hans P.
    Odenthal, Margarete
    Buening, Hildegard
    MOLECULAR THERAPY, 2009, 17 : S316 - S317
  • [45] Prospects of AAV-mediated gene therapy for neuromuscular disease
    Voit, T.
    NEUROMUSCULAR DISORDERS, 2010, 20 (9-10) : 638 - 638
  • [46] AAV-mediated gene targeting methods for human cells
    Iram F Khan
    Roli K Hirata
    David W Russell
    Nature Protocols, 2011, 6 : 482 - 501
  • [47] Advancements in AAV-mediated Gene Therapy for Pompe Disease
    Salabarria, S. M.
    Nair, J.
    Clement, N.
    Smith, B. K.
    Raben, N.
    Fuller, D. D.
    Byrne, B. J.
    Corti, M.
    JOURNAL OF NEUROMUSCULAR DISEASES, 2020, 7 (01) : 15 - 31
  • [48] AAV-mediated gene therapy for hemophilia B.
    High, K
    Arruda, V
    Couto, L
    McClelland, A
    Kay, M
    Glader, B
    Herzog, R
    FASEB JOURNAL, 2000, 14 (08): : A1310 - A1310
  • [49] The progress of AAV-mediated gene therapy in neuromuscular disorders
    Aguti, Sara
    Malerba, Alberto
    Zhou, Haiyan
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2018, 18 (06) : 681 - 693
  • [50] AAV-mediated gene editing lights up the lung
    Yan, Ziying
    Lynch, Thomas J.
    Engelhardt, John F.
    MOLECULAR THERAPY, 2022, 30 (01) : 7 - 9